company background image
A214390 logo

Kyongbo Pharmaceutical KOSE:A214390 Stock Report

Last Price

₩6.19k

Market Cap

₩148.0b

7D

-1.7%

1Y

-7.2%

Updated

14 Mar, 2025

Data

Company Financials

Kyongbo Pharmaceutical Co., Ltd

KOSE:A214390 Stock Report

Market Cap: ₩148.0b

A214390 Stock Overview

Manufactures and sells active pharmaceutical ingredients and finished drugs in South Korea and internationally. More details

A214390 fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance4/6
Financial Health3/6
Dividends0/6

Community vs My Fair Value

Create Narrative

Select a narrative for quick price alerts from the community, or create your own.

Kyongbo Pharmaceutical Co., Ltd Competitors

Price History & Performance

Summary of share price highs, lows and changes for Kyongbo Pharmaceutical
Historical stock prices
Current Share Price₩6,190.00
52 Week High₩8,300.00
52 Week Low₩5,300.00
Beta1.2
1 Month Change1.31%
3 Month Changen/a
1 Year Change-7.20%
3 Year Change-33.37%
5 Year Change21.61%
Change since IPO-81.93%

Recent News & Updates

Kyongbo Pharmaceutical Co., Ltd (KRX:214390) Investors Are Less Pessimistic Than Expected

Feb 19
Kyongbo Pharmaceutical Co., Ltd (KRX:214390) Investors Are Less Pessimistic Than Expected

Recent updates

Kyongbo Pharmaceutical Co., Ltd (KRX:214390) Investors Are Less Pessimistic Than Expected

Feb 19
Kyongbo Pharmaceutical Co., Ltd (KRX:214390) Investors Are Less Pessimistic Than Expected

Kyongbo Pharmaceutical (KRX:214390) Has A Somewhat Strained Balance Sheet

Mar 09
Kyongbo Pharmaceutical (KRX:214390) Has A Somewhat Strained Balance Sheet

What Type Of Shareholders Own The Most Number of Kyongbo Pharmaceutical Co., Ltd (KRX:214390) Shares?

Feb 02
What Type Of Shareholders Own The Most Number of Kyongbo Pharmaceutical Co., Ltd (KRX:214390) Shares?

Kyongbo Pharmaceutical Co., Ltd's (KRX:214390) Financials Are Too Obscure To Link With Current Share Price Momentum: What's In Store For the Stock?

Jan 12
Kyongbo Pharmaceutical Co., Ltd's (KRX:214390) Financials Are Too Obscure To Link With Current Share Price Momentum: What's In Store For the Stock?

Did You Miss Kyongbo Pharmaceutical's (KRX:214390) Impressive 107% Share Price Gain?

Dec 25
Did You Miss Kyongbo Pharmaceutical's (KRX:214390) Impressive 107% Share Price Gain?

Is Kyongbo Pharmaceutical (KRX:214390) A Risky Investment?

Dec 08
Is Kyongbo Pharmaceutical (KRX:214390) A Risky Investment?

Does Kyongbo Pharmaceutical's (KRX:214390) Statutory Profit Adequately Reflect Its Underlying Profit?

Nov 18
Does Kyongbo Pharmaceutical's (KRX:214390) Statutory Profit Adequately Reflect Its Underlying Profit?

Shareholder Returns

A214390KR PharmaceuticalsKR Market
7D-1.7%-3.7%-0.3%
1Y-7.2%-1.5%-7.8%

Return vs Industry: A214390 underperformed the KR Pharmaceuticals industry which returned -1.5% over the past year.

Return vs Market: A214390 matched the KR Market which returned -7.8% over the past year.

Price Volatility

Is A214390's price volatile compared to industry and market?
A214390 volatility
A214390 Average Weekly Movement8.7%
Pharmaceuticals Industry Average Movement4.5%
Market Average Movement5.7%
10% most volatile stocks in KR Market11.9%
10% least volatile stocks in KR Market2.7%

Stable Share Price: A214390's share price has been volatile over the past 3 months compared to the KR market.

Volatility Over Time: Insufficient data to determine A214390's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
1987n/aTae-Young Kimwww.kbpharma.co.kr

Kyongbo Pharmaceutical Co., Ltd manufactures and sells active pharmaceutical ingredients and finished drugs in South Korea and internationally. The company offers general, cephalosporins, and anti-cancer APIs; prescription drugs, including anesthetic, cardiovascular, digestive, and antibiotics; and OTC drugs. It also provides medical devices, including portable X-ray machine and ultrasonic diagnostic equipment; and extraporeal shockwave therapy and temperature control PROBE.

Kyongbo Pharmaceutical Co., Ltd Fundamentals Summary

How do Kyongbo Pharmaceutical's earnings and revenue compare to its market cap?
A214390 fundamental statistics
Market cap₩147.98b
Earnings (TTM)₩4.92b
Revenue (TTM)₩240.51b

30.0x

P/E Ratio

0.6x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
A214390 income statement (TTM)
Revenue₩240.51b
Cost of Revenue₩163.51b
Gross Profit₩77.00b
Other Expenses₩72.07b
Earnings₩4.92b

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)206.00
Gross Margin32.01%
Net Profit Margin2.05%
Debt/Equity Ratio60.4%

How did A214390 perform over the long term?

See historical performance and comparison

Dividends

0.8%

Current Dividend Yield

n/a

Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/03/14 00:27
End of Day Share Price 2025/03/14 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Kyongbo Pharmaceutical Co., Ltd is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Kyung Jun MoonMERITZ Securities Co., Ltd.
Seung-Ho LeeNH Investment & Securities Co., Ltd.